baber/WOPTO huggingface dataset:
Patent NZ-567847-A (NZ)
Title: A mitre box and guide inserts
Inventor: HOWARD ROBERT GRANT
IPC: B27G5/02
Filed: 2008-04-30
Abstract: A mitre box assembly is disclosed, the mitre box assembly includes a mitre box with a plurality of opposing integrally formed slots, and one or more detachable inserts arranged to be located within the slots. The inserts include an integrally formed guiding means for guiding a saw.
Patent NZ-572737-A (NZ)
Title: Methods and apparatus for flexible spectrum allocation in communication systems
Inventor: GOROKHOV ALEXEI
IPC: H04Q7/36
Filed: 2005-03-03
Abstract: An apparatus and a method for allocating a frequency spectrum to a plurality of users are disclosed. The spectrum has a first number of segments and each segment has a second number of clusters associated with a certain sector/cell. The apparatus comprises: means for assigning a first cluster of frequency sub-carriers within a first segment to a first user in a first sector/cell; and means for assigning a second cluster of frequency sub-carriers within a second segment to a second user in a second sector/cell, such that the first cluster and the second cluster have different frequency sub-carrier assignment patterns. Also disclosed are an apparatus and a method for partitioning a frequency spectrum for allocation to a plurality of users. The apparatus comprises: means for partitioning a frequency spectrum into a first number of segments. Each segment has a second number of frequency sub-carriers. The apparatus also comprises means for partitioning a third number of frequency sub-carriers of a segment to a fourth number of clusters associated with a sector/cell, such that at least a fifth number of the clusters have non-overlapping frequency sub-carriers assignment patterns.
Patent NZ-579020-A (NZ)
Title: Preloaded cannula device with a deflectable segment for delivering a curable material into bone
Inventor: KRUEGER JOHN A
IPC: A61B17/88
Filed: 2008-02-08
Abstract: A curable material delivery cannula device for delivering a curable material, such as bone cement, into bone as part of a curable material delivery system is disclosed. The device includes a cannula 36 and a probe. The cannula 36 includes an open proximal end 80, a deflectable segment 88 forming a pre-set curve, a lumen 71, and side orifice(s) 84 adjacent and proximally spaced from, and the distal end 82 and fluidly connected to the lumen 71. When inserted within a guide cannula 22, the deflectable segment 88 straightens. When distally extended from the guide cannula 22, the deflectable segment 88 reverts to the curved shape. The probe can be inserted into the lumen.
Patent NZ-586685-A (NZ)
Title: Foodstuff packaging assembly with a susceptor and a heat shrinking film
Inventor: BONTEMPS ANTOINE
IPC: B65D81/34
Filed: 2009-01-06
Abstract: 586685 Disclosed is an assembly to allow faster and more efficient cooking of a prepackaged food item or meal. The assembly comprises a food product to be heated or cooked in a microwave device, and a packaging surrounding the food product. The packaging has at least one surface to come into contact with the food product and is made at least partly of a susceptor and - a heat shrinking film fixed on at least one surface of the packaging, on the outside of the packaging, so that during microwave heating or cooking the packaging reduces in size in order to bring the susceptor closer to the food product. The heat shrinking film is fixed on two opposite surfaces of the packaging or the heat shrinking film is fixed on one surface of the packaging and can be unfolded to be stuck on the other surface of the packaging, on the outside of the packaging.
Patent NZ-592217-A (NZ)
Title: Methods of treating pulmonary disorders with liposomal amikacin formulations
Inventor: GUPTA RENU
IPC: A61K31/7036
Filed: 2009-10-13
Abstract: 592217 Dis closed is the use of an effective amount of liposomal amikacin in the preparation of a formulation for the treatment of a pulmonary disorder in a patient, wherein: the formulation comprises a lipid and amikacin, the lipid to amikacin ratio is about 0.3 to about 1.0 by weight, the formulation is for administration to the patient for at least two treatment cycles, wherein the treatment cycle comprises an administration period of the formulation of 15 to 75 days, followed by an off period of 15 to 75 days; and the effective dose of the formulation comprises 100 to 2500 mg of amikacin daily during the administration period, and the formulation is for administration to the patient by nebulisation.
Patent NZ-593641-A (NZ)
Title: Extended soluble ph20 polypeptides and uses thereof
Inventor: WEI GE
IPC: C12N9/26
Filed: 2009-12-09
Abstract: 593641 Provided are soluble fragments of PH20 hyaluronidase peptides, which can be used for treating diseases involving an excess of glycosaminoglycans and for treating tumours, cardiovascular and pulmonary diseases. In cancer the peptide works by increasing chemotherapeutic agents into solid tumours. The peptides can in general increase the bioavailability of drugs and other therapeutic agents.
Patent NZ-595416-A (NZ)
Title: Tracking system and method of of entities such as predator and prey animals
Inventor: HOLME CHRISTOPHER DOUGLAS
IPC: A01K11/00
Filed: 2010-03-31
Abstract: An interaction recording system and method for recording data associated with an interaction between a first entity and a second entity are disclosed. The interaction recording system (1) comprises a first unit (2) associated with the first entity, a second unit (3) associated with the second entity. The first unit comprises a first communication device for communicating data, a first controller, a first storage medium storing data associated with the first entity, and a passive detector. The second unit comprises a second communication device for communicating data, a second controller, and a second storage medium for storing data. The passive detector is operable to determine the presence of the second unit within a range of the first unit indicating an interaction between the second entity and the first entity. The first controller is operable, following determination by the passive detector of the presence of the second unit within the range, to activate the first unit from a default lower power mode to a higher power mode in which the first unit is operable to communicate, via the first communication device, some or all of the data stored on the first storage medium, including the first entity data, to the second unit for receipt via the second communication device. The second controller is operable to determine data' associated, with the interaction and to' record the determined interaction data and the received communicated data, including the first entity data, on the second storage medium.
Patent NZ-595490-A (NZ)
Title: Derivatives of kahalalide F for the treatment of cancer
Inventor: PALOMERA FERNANDO ALBERICIO
IPC: A61K38/00
Filed: 2004-09-09
Abstract: Disclosed is a compound based on the structure of kahalalide F wherein the 11 position has been substituted with [hCh11]-KF, [Gly11]-KF, [Phe11]-KF, [Ala11]-KF, [Leu11]-KF, [DVal11]-KF, [Pro11]-KF, [Gln11]-KF, [Orn11]-KF, [Thr11]-KF, [Glu11]-KF. The compound is useful as a cancer treating agent, particularly where the cancer is prostate cancer, breast cancer, hepatocellular carcinoma, melanoma, colorectal cancer, ovarian cancer, NSCL cancer, epithelial cancer, pancreatic cancer or a tumour that overexpresses the Her2/neu oncogene.
Patent NZ-601967-A (NZ)
Title: Pde10 inhibitors and related compositions and methods
Inventor: WHEELER THOMAS NEIL
IPC: C07D417/10
Filed: 2011-03-10
Abstract: Disclosed are 1-(5-phenyl-furan-2-yl)-2-alkoxy-2-aryl-ethanone derivatives as represented by the general formula (I), or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, wherein: A is a heteroaryl moiety as defined herein and preferably selected from furan-2-yl, R1 is alkyl, haloalkyl, aralkyl, aryl, -(CH2)nO(CH2)mCH3 or -CH2)nN(CH3)2; R2 is (i) substituted or unsubstituted aryl or (ii) substituted or unsubstituted heterocyclyl; R3 is substituted or unsubstituted aryl; n is 1, 2, 3, 4, 5 or 6; and m is 0, 1, 2, 3, 4, 5 or 6; and wherein “alkyl” means a straight chain or branched, noncyclic or cyclic, unsaturated or saturated aliphatic hydrocarbon radical containing from 1 to 6 carbon atoms, and wherein the remaining substituents are as defined herein. Representative compounds include 1-(5-(4-bromo-3,5-dimethoxyphenyl)furan-2-yl)-2-methoxy-2-(4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl)ethanone, 2-methoxy-2-(4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl)-1-(5-(3,4,5-trimethoxyphenyl)furan-2-yl)ethanone and 1-(5-(4-chloro-3,5-dimethoxyphenyl)furan-2-yl)-2-ethoxy-2-(4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl)ethanone. Also disclosed is a pharmaceutical composition comprising a compound as defined above, and a pharmaceutically acceptable carrier or diluent, for treating neurological disorders such as psychotic disorders, anxiety disorders, movement disorders and/or neurological disorders such as Parkinson’s disease, Huntington’s disease, Alzheimer’s disease, encephalitis, phobias, epilepsy, aphasia, Bell’s palsy, cerebral palsy, sleep disorders, pain, Tourette’s syndrome, schizophrenia, delusional disorders, bipolar disorders, post-traumatic stress disorders, drug-induced psychosis, panic disorders, obsessive-compulsive disorders, attention deficit disorders, disruptive behavior disorders, autism, depression, dementia, cognitive disorders, epilepsy, insomnias and multiple sclerosis.
Patent NZ-602968-A (NZ)
Title: Extended release formulation containing a wax
Inventor: CHATTARAJ SARAT C
IPC: A61K9/20
Filed: 2009-03-18
Abstract: NZ 602968 The disclosure relates to an extended release pharmaceutical formulation comprising: (a) an extended release portion comprising an active pharmaceutical ingredient (API) and a wax selected from the group consisting of waxes of animal or vegetable origin, synthetic waxes, semi-synthetic waxes, and high-melting pharmaceutically acceptable water-insoluble waxes; and (b) an immediate release portion comprising an API in an amount of from 5% w/w to 8% w/w of the immediate release portion; said extended and immediate release portions both comprising the same API; and wherein the extended release portion comprises a mixture of a free base and a salt of the API in a range of from 1:2 to 2:1.
Patent NZ-613219-A (NZ)
Title: Heterocyclic containing entities, compositions and methods
Inventor: WILSON TROY EDWARD
IPC: A61K31/4375
Filed: 2009-01-05
Abstract: Disclosed herein is a tolylthieno[2,3-d)pyrimidin derivatives of formula (IX), wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful for inhibiting catalytic activity of phosphatidyl inositol-3 kinase (PI3 Kinase) present in a cell and therefore are useful in the treatment of cancer, bone disorders, inflammatory disease, immune disease, nervous system disease, metabolic disease, respiratory disease, thrombosis, or cardiac disease.
Patent NZ-618608-A (NZ)
Title: Adjustable lift cord anchor for movable rails in coverings for architectural openings
Inventor: SPRAY JEFFREY L
IPC: E06B9/388
Filed: 2012-06-07
Abstract: 618608 An adjustable anchor (20) for anchoring a lift cord (32) in a movable rail (28) of a covering (22) for an architectural opening includes a housing which is releasably positionable interiorly of the movable rail (28) in alignment with a lift cord (32) for the covering with the anchor (20) including a rotatable drum within the housing and around which the lift cord (32) can be wrapped or unwrapped by rotating movement of the with a tool (34). Two distinct systems are provided for releasably securing the drum in any selected position to retain the amount of lift cord (32) wrapped therearound with the two systems acting in mutually perpendicular planes for reliable anchoring of the lift cord (32).
Patent NZ-620270-A (NZ)
Title: Carton feeding system
Inventor: KARST PETE
IPC: B65H5/06
Filed: 2012-09-04
Abstract: A carton feeding system (10) is provided for feeding cartons from a magazine (11) for presenting a stack of cartons to a downstream carton conveyor such as for a product packaging machine. A carton picking device removes a selected carton from the stack of cartons within the magazine, after which the carton is engaged between a carton engaging segment (46) of the primary segment wheel (40) and a draw roller, which pulls the carton from the magazine and feeds the carton along a first path (75) of travel. A secondary segment wheel (80) engages and redirects a leading portion of the carton toward a second path (82) of travel. The carton then is fed along its second path of travel toward engagement between a pair of downstream nip rolls that feed the carton into the downstream carton conveyor.
Patent NZ-622542-A (NZ)
Title: Production of adipic acid and derivatives from carbohydrate-containing materials
Inventor: JIANG HONG
IPC: C08G69/26
Filed: 2010-06-11
Abstract: Disclosed herein are processes for the chemocatalytic conversion of a glucose source to an adipic acid product of formula II wherein R1 and X are defined in the specification. The process comprises reacting a hydrodeoxygenation substrate of formula I, such as glucaric acid, and hydrogen gas in the presence of a hydrodeoxygenation catalyst and a halogen source. In one embodiment the hydrodeoxygenation catalyst comprises a first metal selected from Ru, Rh, Pd, Pt, and combinations thereof and a second metal selected from Mo, Ru, Rh, Pd, Ir, Pt, and Au. Additionally disclosed are products produced from the adipic acid products and processes for the preparation thereof. Additionally disclosed is a process of preparing glucaric acid or lactone thereof, the process comprising: reacting glucose with oxygen in the presence of a heterogeneous oxidation catalyst comprising a metal selected from the group consisting of Pd, Pt, and a combination thereof to convert at least a portion of the glucose to glucaric acid or lactone thereof, wherein the pH of the reaction mixture is less than 7 and the reaction is conducted in the substantial absence of added base, and at least 50% of the glucose is converted to glucaric acid or lactone thereof.
Patent NZ-628042-A (NZ)
Title: Pump efficiency determining system and related method for determining pump efficiency
Inventor: DEVINE THOMAS W
IPC: F04D15/00
Filed: 2013-02-01
Abstract: Disclosed is a method for determining efficiency of at least one pump (120) configured in a pumping facility. The method includes the steps of measuring various operating parameters of the at least one pump (120); transmitting the measured operating parameters to a processing system (180); and calculating the actual efficiency of the at least one pump (120) based on the measured operating parameters. The method further includes the step of comparing the calculated efficiency of the pump (120) to an expected efficiency of the pump (120) under the same operating conditions; and providing an alert if the compared actual efficiency deviates from the expected efficiency by a predetermined amount. The alert includes a cost estimate of the inefficiency.
Patent NZ-700195-A (NZ)
Title: Compositions comprising deoxycholic acid
Inventor: PRASAD ACHAMPETA RATHAN
IPC: C07J21/00
Filed: 2014-09-19
Abstract: Disclosed herein are compositions comprising deoxycholic acid and a steroidal deoxycholic acid precursor or byproduct containing a 12-B hydroxy group wherein if the DCA precursor or byproduct is 12-β DCA or an ester thereof, or a pharmaceutically acceptable salt of each thereof, then the DCA precursor or byproduct is present in less than 6% of the total amount of the DCA or a pharmaceutically acceptable salt thereof and the DCA precursor or byproduct. Also disclosed is the use of these compositions in the manufacture of a medicament for treating conditions such as obesity and fat redistribution syndrome.
Patent NZ-710299-A (NZ)
Title: Methods, systems, and software for identifying bio-molecules with interacting components
Inventor: COPE GREGORY ALLAN
IPC: G16B35/10
Filed: 2014-01-29
Abstract: The present invention provides methods for rapidly and efficiently searching biologically-related data space. More specifically, the present invention provides methods for identifying bio-molecules with desired properties, or which are most suitable for acquiring such properties, from complex bio-molecule libraries or sets of such libraries. The present invention also provides methods for modeling sequence-activity relationships, including but not limited to stepwise addition or subtraction techniques, Bayesian regression, ensemble regression and other methods. The present invention further provides digital systems and software for performing the methods provided herein.
Patent NZ-713220-A (NZ)
Title: Wind turbine and a lightning protection unit for a wind turbine
Inventor: EDEN GEORG
Filed: 2014-05-08
Abstract: The invention addresses improving lighting protection means and relates to a wind turbine. The wind turbine indcludes a nacelle, a rotor which has at least two rotor blades, the rotor blades each having a rotor blade root, at least one metallic conductor, for conducting a lightning strike, and a conducting ring connected thereto, the ring being disposed in the region of the rotor blade root, at least one lightning protection unit being fastened to the non-rotating part of the nacelle in such a manner that advantageously the at least one lightning protection unit lies on the ring on the rotor blade in order to divert lightning striking the rotor blade, wherein the lightning protection unit has two rollers and a lightning rod, a free end of the lightning rod being separated from an outer end of the rollers by a distance that defines a spark gap between the free end of the lightning rod and the ring on the rotor blade, wherein advantageously the rollers are electrically non-conducting.
Patent NZ-714245-A (NZ)
Title: Producing beer using a wort concentrate
Inventor: TOOMBS PETER
IPC: C12C11/00
Filed: 2012-03-28
Abstract: Disclosed is method for producing beer comprising: -forming a mixture of a wort concentrate having a specific gravity of at least 1.085 kg/m3 with water, an acid neutralising solution, and yeast; -fermenting the mixture; -monitoring fermentation conditions, and on determining with at least one processor (CPU) that predetermined fermentation conditions have been met, cooling the fermented mixture to between about zero and about four degrees Celsius; -adding yeast finings; -filtering the fermented mixture; and -carbonating the filtered fermented mixture such that beer is produced.
Patent NZ-729252-A (NZ)
Title: Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
Inventor: SCHNUTE MARK EDWARD
IPC: C07D401/14
Filed: 2015-09-22
Abstract: The present invention provides methyl- and trifluoromethyl-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating RORγ activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmaceutical compositions thereof. The methyl- and trifluoromethyl-substituted pyrrolopyridines are compounds of Formula I or pharmaceutically acceptable salts thereof. X, Y, W and R1 are as defined herein.
Patent NZ-730364-A (NZ)
Title: Vent assembly and reservoirs including the same
Inventor: MULVANEY CLAUDIA M
IPC: B05B7/24
Filed: 2013-07-25
Abstract: Vent assemblies movable between a vented position and a non-vented position are described along with reservoirs in which the vent assemblies may be used. The vent assemblies each include an aperture and a closure member. The closure member is configured for movement along a cam surface incorporating the aperture to generate a compressive force such that a sealing surface on the closure member is forced against the wall of the reservoir and over the aperture such that the vent assembly is in the non-vented position. The closure member movement may be, e.g., rotational or linear (i.e., translational) when moving between the vented and unvented positions. Such arrangements provide a vent assembly which is adjustable between the vented and unvented positions so as to provide flexibility to a user.
Patent NZ-757513-A (NZ)
Title: Machine monitoring
Inventor: SCOTT JOHN
IPC: G01H3/00
Filed: 2017-03-17
Abstract: A monitoring system for monitoring a machine, the monitoring system including at least one monitoring device and one or more processing systems. The monitoring device includes a housing, a coupling that physically attaches the housing to the machine, a plurality of sensors, the plurality of sensors including a vibration sensor that senses vibration transmitted from the machine to the vibration sensor at least in part via the coupling, a monitoring device processor that acquires sensors signals from the plurality of sensors and generates sensor data at least partially in accordance with signals from the sensors, and a transmitter that transmits the sensor data. The one or more processing systems receive the sensor data, analyse the sensor data to determine a machine status and either store an indication of the machine status as part of machine status data associated with respective machine or cause a status indication indicative of the machine status to be displayed.
Patent NZ-773969-A (NZ)
Title: Exterior wall structure of building
Inventor: SATO YUTAKA
IPC: E04B2/42
Filed: 2021-03-15
Abstract: An exterior wall structure of a building, the exterior wall structure comprising: a cavity batten installed above a foundation such that the cavity batten is included in a lower end of the exterior wall structure of the building, the foundation supporting the building; a face panel fixed to the cavity batten such that the face panel is located on an outdoor side of the cavity batten; a flashing between the exterior wall structure and the foundation, the flashing being located on a lower side of the cavity batten; a through hole for water drainage, the through hole vertically penetrating the cavity batten; a drainage canal provided in part of the flashing, a panel located on an indoor side of the face panel; and a hollow layer between the face panel and the panel, the flashing being provided to cover a space between the face panel and the foundation and a support structure disposed in the space, the flashing having a tilted part extending obliquely downward toward the indoor side, a projection part rising upward from a portion of the tilted part, and a flashing part extending further downward from the tilted part, a portion of the tilted part being provided with a drainage canal, the projection part, which is configured to dam water, rising upward from an indoor-side portion of the tilted part, the hollow layer being located above the timber yoke, and being open downward through the plurality of through holes formed in the timber yoke, the exterior wall structure being configured such that water dropped on to the tilted part through the through hole is drained through the drainage canal to the flashing part, and is drained along an upper surface of the flashing part to the outdoor side of the flashing.
Patent PT-104239-A (PT)
Title: Sistema anti-fuga em postos de abastecimento de combustível
Inventor: BARROS JOAO FRANCISCO CUNHA E
IPC: E01F13/04
Filed: 2008-10-28
Abstract: O PRESENTE INVENTO DIZ RESPEITO A UM SISTEMA ANTI-FUGA EM POSTOS DE ABASTECIMENTO DE COMBUSTÍVEL, DO TIPO DOS QUE APRESENTAM UMA BARREIRA MONTADA NA SUPERFÍCIE DO PAVIMENTO. É ESSENCIALMENTE CARACTERIZADO POR ASSOCIAR À REFERIDA BARREIRA UMA UNIDADE DE CONTROLO INTELIGENTE CAPAZ DE ANALISAR E ACTUAR EM CONFORMIDADE COM CONDIÇÕES PREDEFINIDAS PELO GESTOR DO ABASTECIMENTO, UNIDADE ESSA QUE EFECTUA A MONITORIZAÇÃO DE UM MÓDULO ANTI-FUGA SINCRONIZANDO-O COM O MECANISMO DA BOMBA (4), COM O SISTEMA DE PAGAMENTO OU COM O OPERADOR DA CAIXA CENTRAL.